![]() |
|
|
Vol. 291, Issue 2, 710-716, November 1999
Department of Pharmacology, Tokyo University of Pharmacy and Life
Science, Hachioji, Japan
We examined a possible mechanism of action of an ATP-sensitive
potassium (KATP) channel opener, YM934, for the improvement of energy metabolism in hearts subjected to 35-min ischemia and 60-min
reperfusion. The treatment with 30 nM YM934 for the final 15 min of
preischemia enhanced postischemic recovery of left ventricular developed pressure, attenuated the postischemic rise in left
ventricular end-diastolic pressure, and suppressed the release of
creatine kinase and ATP metabolites during reperfusion. The treatment
also restored myocardial ATP and creatine phosphate contents and
attenuated the decrease in mitochondrial oxygen consumption rate during
reperfusion. The higher mitochondrial function was also seen in
YM934-treated hearts at the end of ischemia. In another set of
experiments, myocardial skinned bundles were incubated for 30 min under
hypoxic conditions in the presence and absence of YM934, and then
mitochondrial oxygen consumption rate was determined. Hypoxia decreased
the mitochondrial oxygen consumption rate of skinned bundles to
approximately 40% of the prehypoxic value. In contrast, the treatment
of skinned bundles with 30 nM YM934 preserved the mitochondrial oxygen
consumption rate during hypoxia. The effect of YM934 on the hypoxic
skinned bundles was abolished by combined treatment with either the
KATP channel blocker glyburide or the mitochondrial
KATP channel blocker 5-hydroxydecanoate in a
concentration-dependent manner. The results suggest that YM934 is
capable of attenuating ischemia/reperfusion injury of isolated perfused
hearts due to preservation of mitochondrial function during ischemia,
probably through opening of mitochondrial KATP channels.
This article has been cited by other articles:
![]() |
K. Naitoh, Y. Ichikawa, T. Miura, Y. Nakamura, T. Miki, Y. Ikeda, H. Kobayashi, M. Nishihara, K. Ohori, and K. Shimamoto MitoKATP channel activation suppresses gap junction permeability in the ischemic myocardium by an ERK-dependent mechanism Cardiovasc Res, May 1, 2006; 70(2): 374 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Rourke Evidence for Mitochondrial K+ Channels and Their Role in Cardioprotection Circ. Res., March 5, 2004; 94(4): 420 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Hausenloy, H. L Maddock, G. F Baxter, and D. M Yellon Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res, August 15, 2002; 55(3): 534 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Lee, S.-F. Su, T.-F. Chou, and C.-H. Tsai Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty J. Am. Coll. Cardiol., March 6, 2002; 39(5): 871 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanonaka, K.-I. Furuhama, H. Yoshida, K. Kakuta, Y. Miyamoto, W. Toga, and S. Takeo Protective effect of heat shock protein 72 on contractile function of perfused failing heart Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H215 - H222. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ozcan, E. L. Holmuhamedov, A. Jahangir, and A. Terzic Diazoxide protects mitochondria from anoxic injury: Implications for myopreservation J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0298 - 306. [Abstract] [Full Text] [PDF] |
||||